Clariane Shares Slide 2.85% Approaching Critical Support at €3.40
Shares of the European dependency care specialist dropped 2.85% this Thursday, to €3.61, amid a significant downturn in the CAC 40. The decline brings the share price close to a closely watched technical threshold, with the publication of the quarterly revenue expected in three weeks.
During the session, the CAC 40 fell by 1.25% to around 7,881 points, while the SBF 120 dropped 1.26%. In this tense atmosphere, Clariane intensified the downward movement with a decline of 2.85% from the previous day's close, to €3.72. The stock now shows a decrease of 8.24% over three months and 14.62% over a year, confirming an unfavorable long-term trend despite a slight rebound of 4.52% observed over the last seven days. No specific news about the group was released this Thursday. The next dates on the financial calendar are the communication of the first quarter 2026 revenue, scheduled for April 23, followed by the general assembly planned on May 12. These events are the next catalysts that could alter the stock's trajectory.
Technical Analysis
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Graphically, the price of €3.61 is significantly below the 50-day moving average, which stands at €3.82, and even more so from the 200-day moving average at €4.14. This gap indicates a medium-term bearish dynamic. The stock is approaching the support identified at €3.40; a downward breach of this level could increase selling pressure, while the resistance at €4.07 remains distant from the current price. The RSI, an indicator measuring the speed and magnitude of price changes, remains at 51, in a neutral zone. This level indicates neither overbuying nor overselling, but reflects a lack of directional conviction in the short term. The negative beta of -0.37 assigned to the stock also indicates an inverse correlation with the market, which makes its behavior atypical compared to the overall Paris market. However, this characteristic did not play out this Thursday, as the stock declined more sharply than the reference index.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.